carfentanil

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Twitter
Facebook
Flickr
YouTube
RSS
E-mail updates

Contact

The EMCDDA is located at:
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact information >>

Feedback and support

General enquiries
EMCDDA publications
Website support
Legal notice

The EMCDDA is an agency of the European Union.

Content tagged with carfentanil

EU Early Warning System on NPS

EMCDDA–Europol 2017 Annual Report on the implementation of Council Decision 2005/387/JHA

Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances

Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System

European Drug Report 2018: Trends and Developments

EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil)

Meeting on the risk assessment of seven new psychoactive substances

Molecular structure of carfentanil

About the EMCDDA

Follow us

Contact

Feedback and support